Clinical trial of a herbal drug for body swelling.

Phase 2 clinical trial for assessment of safety and efficacy of a multi component botanical therapeutic (SKBSITA) in patients suffering from edema.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010676

Enrollment

280

Registered

2017-11-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from edema.

Interventions

Intervention1: SKBSITA: Dose: Two 500 Mgs capsules (equivalent to 5 Gms whole powder)

Frequency: Every 3-4 hours

Route of administration: Oral Duration of therapy: about 15 days Control Intervention1: Placebo: Two 500 Mgs capsules (equivalent to 5 Gms whole powder)

Route of administration: Oral Duration of therapy: about 15 days

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from edema.

Exclusion criteria

Exclusion criteria: Patients not suffering from edema.

Design outcomes

Primary

Measure	Time frame
Complete freedom from edema.Timepoint: 2 days	—

Secondary

Measure	Time frame
Complete freedom from edema.Timepoint: 15 days	—

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026